|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Impact of contraception on gynecologic cancers. |
| AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 1993 Jun;168(6 Pt |
| In considering the appropriate contraceptive method for a particular woman, the potential effect of that method on her |
| risk of developing cancer of the breast, cervix, endometrium, or ovary is crucial. Among the most closely studies of |
| the risk factors for gynecologic neoplasm has been the potential role of contraceptives, especially oral |
| contraceptives (OCs), IUDs, and injectable progestins. Physicians need to consider the potential impact of these |
| agents in the disease process, therapy for the disease, future fertility, and the health of the fetus. Although much of |
| the epidemiologic data is inconsistent and difficult to interpret, most studies find no association between OC use |
| and increase risk of breast cancer, except possibly in young women (<45 years of age) with prolonged use. OC use |
| may protect against benign breast disease. Data concerning OC use and cervical neoplasm are confounded by |
| several interacting variables, the most important of which is that OC users tend to have more Papanicolaou smears |
| than nonusers. Some studies have indicated an increased risk of 2-4-fold after 10 years of use. OC use provides |
| clear protection against endometrial and ovarian cancer, an effect that persists for years after discontinuation. Less |
| data have been collected regarding the relationship between IUDs and injectable hormone preparations and various |
| types of cancer. No evidence suggests that the IUD predisposes to the development of preneoplastic conditions of |
| the cervix, nor to endometrial or ovarian cancer. A reliable form of contraception is indicated in women with cancer of |
| any kind that may require chemotherapy or radiation, because these treatments can have adverse effects on the |
| fetus, especially if given during the first trimester. (PubHealth.info Document ID: CONT2T 4550-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Impact of contraception on gynecologic cancers.", is(are) |
| Herbst AL; Berek JS. The source of this article is "AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. |
| 1993 Jun;168(6 Pt 2):1980-5.". This article was published in 1993 in English language(s). (PubHealth.info® |
| Document ID: CONT2T 4550-06. All rights reserved with PubHealth.info) PIN: 9550 |
| This article is peer-reviewed. |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |